Argus, IndusLaw acts on Mynvax $4.2 million fund raise from Accel and others

LetsVenture and a few early-stage angel investors also participated in this round.

Bar & Bench

Published:23rd Aug, 2021 at 3:39 PM

Mynvax, a vaccine technology startup, incubated by the Society for Innovation and Development (SID) has raised $4.2 million (₹31 crores) in its Series A funding round led by Accel.

Argus Partners advised Mynvax and the team was led by Partner Vinod Joseph along with Associate Anurag Prasad.

IndusLaw acted for Accel and the team was led by Partner Anindya Ghosh. along with Principal Associate Ashwin Krishnan and Associate Manisha Nayak.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Argus, IndusLaw acts on Mynvax $4.2 million fund raise from Accel and others

LetsVenture and a few early-stage angel investors also participated in this round.

Also Read

AP High Court seeks Centre's response on plea challenging BNSS provision allowing handcuffing of accused

Punjab & Haryana High Court confers Senior designation on 76 advocates

NCLT Ahmedabad admits BluSmart subsidiary to CIRP over unpaid Google Maps services

Karnataka High Court seeks State’s response to plea challenging Udupi Civil Court shift to Brahmavar

Bombay High Court restrains hacker group from leaking data stolen from insurer Generali Central